You can't run from inflammation: Lower extremity ischemia, hypoxia signaling, and macrophage subtypes

Circulation Research

Volumn 110, Issue 8, 2012, Pages 1045-1046

  Moslehi, Javid ^a,b   Libby, Peter ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD FLOW; BONE MARROW TRANSPLANTATION; CARDIOVASCULAR DISEASE; CLAUDICATION; CYTOKINE PRODUCTION; EDITORIAL; ENDURANCE; ENZYME ACTIVITY; GENE THERAPY; HOST RESISTANCE; HUMAN; HYDROXYLATION; HYPOXIA; IMMUNE SYSTEM; INFLAMMATION; INNATE IMMUNITY; LEG ISCHEMIA; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SKELETAL MUSCLE; TREADMILL EXERCISE;

EID: 84859907508     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/RES.0b013e318255409e     Document Type: Editorial

References (12)

1. Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell. 2012;148:399-408.
2. Kaelin WG Jr, Ratcliffe PJ. Oxygen sensing by metazoans: The central role of the hif hydroxylase pathway. Mol Cell. 2008;30:393-402. (Pubitemid 351681994)
3. Minamishima YA, Moslehi J, Bardeesy N, Cullen D, Bronson RT, Kaelin WG Jr. Somatic inactivation of the phd2 prolyl hydroxylase causes polycythemia and congestive heart failure. Blood. 2008;111:3236-3244.
4. Takeda Y, Costa S, Delamarre E, et al. Macrophage skewing by phd2 haplodeficiency prevents ischaemia by inducing arteriogenesis. Nature. 2011;479:122-126.
5. Polverini PJ, Cotran PS, Gimbrone MA Jr, Unanue ER. Activated macrophages induce vascular proliferation. Nature. 1977;269:804-806. (Pubitemid 8208827)
6. Ito WD, Arras M, Winkler B, Scholz D, Schaper J, Schaper W. Monocyte chemotactic protein-1 increases collateral and peripheral conductance after femoral artery occlusion. Circ Res. 1997;80:829-837. (Pubitemid 27230057)
7. Minamishima YA, Moslehi J, Padera RF, Bronson RT, Liao R, Kaelin WG Jr. A feedback loop involving the phd3 prolyl hydroxylase tunes the mammalian hypoxic response in vivo. Mol Cell Biol. 2009;29: 5729-5741.
8. Aragones J, Schneider M, Van Geyte K, et al. Deficiency or inhibition of oxygen sensor phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat Genet. 2008;40:170-180. (Pubitemid 351171394)
9. Fu J, Menzies K, Freeman RS, Taubman MB. Egln3 prolyl hydroxylase regulates skeletal muscle differentiation and myogenin protein stability. J Biol Chem. 2007;282:12410-12418. (Pubitemid 47100642)
10. Mazzone M, Dettori D, Leite de Oliveira R, et al. Heterozygous deficiency of phd2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell. 2009;136:839-851.
11. Hsieh MM, Linde NS, Wynter A, Metzger M, Wong C, Langsetmo I, Lin A, Smith R, Rodgers GP, Donahue RE, Klaus SJ, Tisdale JF. Hif prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques. Blood. 2007;110:2140-2147. (Pubitemid 47443933)
12. Creager MA, Olin JW, Belch JJ, Moneta GL, Henry TD, Rajagopalan S, Annex BH, Hiatt WR. Effect of hypoxia-inducible factor-1alpha gene therapy on walking performance in patients with intermittent claudication. Circulation. 2011;124:1765-1773.